Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Recruiting · NCT07046806 · Registry updated 2025-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hereditary Complement Deficiency Diseases, Hypersensitivity, Immediate, Primary Immunodeficiency Diseases, Skin and Connective Tissue Diseases, angioedema, cardiovascular disorder, hereditary angioedema, hereditary disease, immune system disorder, inborn error of immunity, skin disorder, skin vascular disease, urticaria, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2025-07-02 | NCT07046806 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute for Asthma and Allergy | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute For Asthma & Allergy | Wheaton | United States | 2 |